Navigation Links
NanoFUSE Biologics a One of a Kind Bioactive Glass and DBM Expands into Panama

On Thursday, August 8, 2019, NanoFUSE Biologics will launch its one-of-a-kind biologic in Panama City, Panama. NanoFUSE is working in conjunction with its new partner PTY Medical Group to continue its global launch of the FDA-cleared, patented biologic.

The NanoFUSE event will unite more than 40 top orthopedic and spine surgeons to further inform them about the features and characteristics of the unique biologic. The launch will take place at the Sortis Hotel at 7:30 pm.

NanoFUSE Biologics is the only bioactive glass that is FDA-cleared to be combined with DBM. Bioactive glass has been clinically proven in orthopedics for over 30 years, but NanoFUSE Biologics is the first to use bioactive glass to create a revolutionary and patented biologic.

Philip Hamann, NanoFUSE’s VP of Sales in Latin America, Spain & Portugal, Archie Yamada, NanoFUSE’s VP Product Business Development, and Gustavo Pinilla, PTY Medical Group General Manager, will present at the event.

Philip Hamann said, “Introducing NanoFUSE to Panama represents the beginning of many more launches in the region. As we move forward and work with strategic partners, I have no doubt that NanoFUSE will be the number one biologic solution for not just surgeons, but also for their patients. Our commercial partner in Panama, PTY, has done a great job organizing this top-notch event. NanoFuse’s effort to position itself in Panama is just one more step in its global expansion.”

Jake Lubinski, President of NanoFUSE said, "NanoFUSE is clinically proven and reduces the need for autograft. We're proud to offer the highest quality of DBM and synthetic biologics to treat patients in Panama. The recent release of our 100% fully synthetic bioactive glass strip, NanoSTRIP positions NanoFUSE to be the worldwide leader in bioactive glass and synthetic biologics."

To attend this NanoFUSE event in Panama, or to learn how you can start using NanoFUSE, please contact Rosa Martinez at

About NanoFUSE Biologics

NanoFUSE is the synergistic blend of osteoinductive DBM combined with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in all orthopedic surgery. NanoFUSE Biologics is a KICVentures portfolio company and is distributed by SpineFrontier.

About KICVentures

KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed, NanoFUSE and SpineFrontier. It has headquarters in Boston, MA.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine news :

1. NanoFUSE Biologics Continues Global Expansion with Launch in Thailand
2. KICVentures Will Exhibit Portfolio Companies, AxioMed, NanoFUSE and SpineFrontier at AANS Annual Meeting
3. KICVentures Unveils New Investment Opportunities in AxioMed® and NanoFUSE™ Biologics for 2019 at AAOS
4. KICVentures Announces Investment Opportunity to Prepare AxioMed and NanoFUSE Biologics for Acquisition
5. FDAnews Announces — The Accelerated Approval Pathway for Drugs and Biologics: Final Labeling Guidance Webinar, April 25, 2019
6. Techniques for Achieving High Dose Accuracy to be Presented by Catalent Biologics Experts at ISPE Aseptic Conference
7. Solutions for Assay Automation to be Presented by Catalent Biologics at BEBPA US Bioassay Conference
8. Lone Peak Biologics is Excited to Announce its Newest Groundbreaking Regenerative Product: AmnioShot™
9. Catalent to Host Workshop with Leading Biologics Experts on Advanced Protein Development and Delivery at Upcoming Drug Delivery Partnerships Conference
10. Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative to Create Antibodies for Malaria Vaccine Research and Development
11. MediVet Biologics Announces Publication on Immunotherapy Vaccine for Canine Cancer
Post Your Comments:
(Date:2/19/2020)... ANTONIO (PRWEB) , ... February 19, 2020 , ... ... device and implant manufacturer, will highlight its growing product portfolio for lower extremities ... 18-22 at the Henry B. Gonzalez Convention Center. The Trigon® Ti Stand-Alone Osteotomy ...
(Date:2/19/2020)... ... February 19, 2020 , ... SafiraMD Medical ... for FDA-cleared CoolSculpting®, the world’s most popular non-invasive fat reduction treatment. Their CoolEvent ... the Halcyon Village Center in Alpharetta, Georgia. The CoolEvent will feature live demonstrations, ...
(Date:2/16/2020)... ... February 16, 2020 , ... Canadian digital healthcare portal Ask The ... who are concerned about the Coronavirus. , "It is our duty and it is ... this deadly virus" said Prakash Chand, CEO of Ask The Doctor. , Doctors and ...
(Date:2/15/2020)... ... ... Sister companies, Special Learning Inc. and ABA Business Growth, are offering ABA ... the challenges, risks, and opportunities of private equity investment and acquisition in the field. ... , Since 2010, more than 60 private equity firms have entered ...
(Date:2/14/2020)... ... 2020 , ... ScripHessco has announced the release of their ... down the benefits of chiropractic care during pregnancy and how to find a ... beneficial to the mother’s health. Seeing a chiropractor during pregnancy leads to a ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... February 14, 2020 , ... February ... between the organisms that cause inflammatory gum disease (e.g., periodontitis) and systemic inflammatory ... , offers new tools in the fight against common dental problems such as ...
(Date:2/14/2020)... ... ... Dignitana AB , world leader in scalp cooling innovation, announced today that ... events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s reach to hundreds ... MORE THAN PINK Walk® events in key Dignitana markets throughout year. , Dignitana is ...
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... donation of $55,496 to Children’s Healthcare of Atlanta (Children’s) raised through their annual ... a portion of all new or pre-owned vehicle sales between November 29, 2019, ...
Breaking Medicine Technology: